Abstract
The escalating impact of dengue infection on health and mortality is a critical global issue. Therefore, it is of interest to assess the current trends of dengue infection in India. We searched through a wide range of internet databases to gather comprehensive studies on the incidence, prevalence, sero-prevalence, cost effectiveness and mortality rate of dengue infection in India from 2014 to 2023 (10 years) in a total of 127 studies. Analysis shows significant heterogeneity (diversity) in reported outcomes (p-values < 0.001). Thus, public health strategies should include early detection of dengue infection in our country.
Keywords: Dengue, dengue virus, burden of dengue, sero-prevalence, prevalence
Background:
Dengue is caused by an arbovirus of the Genus Flavivirus and Family Flaviviridae, is one of the most prevalent, fast-spreading vector-borne diseases impacting people [1]. As a result, research has shown that dengue disease may be clinically characterized as either mild dengue, dengue with or without warning signals, or severe dengue [1, 2]. According to a study, an estimated 105 million infections occur worldwide every year, only 51 million of which are symptomatic, making it a major public health issue [3]. Due to increasing worldwide travel and the geographical expansion of the Aedes vector mosquitoes, dengue virus are transmitted on all major continents, with new cases occurring and spreading to formerly non-endemic locations [4]. The primary dengue infection is presumed to provide permanent sterilizing immunity against homologous serotypes; however, exceptions exist in human and animal experimental investigations [5, 6]. Secondary infection (SC) with an un-encountered serotype often leads to classical dengue fever (fever) and is linked to a heightened risk of severe sequelae [7, 8]. This is a significant risk factor for the heightened severity of dengue fever via the antibody-dependent enhancement (ADE) pathway [9]. A second dengue fever occurring within two years after the first infection is likely to be an asymptomatic infection, as shown by the neutralizing antibody titer [10]. Therefore, it is of interest to assess dengue fever in India with the help of systematic review (SR) and meta-analysis (MA).
Material and Method:
Protocol development:
In the present manuscript, written according to the PRISMA checklist, [11] only the scientific evidence of dengue infection current Trent in India was investigated. This SR protocol was a priori registered in The International Prospective Register of SR (Registration No: CRD42024552341).
Search strategy, Databases & Selection criteria:
We have searched in electronic databases such as Cochrane Library, Medline, Web of Science (WoS), PubMed, Scopus & Google Scholar for publications published between January 2014 and December 2023. Appendix I: Search Strategy contains all of the search strategy's details. We have specifically used date/year as a filter to search three databases i.e. (PubMed, Scopus/Elsevier and Embase) from May 24-27, 2024. The Covidence application was used to screen abstracts.
Inclusion criteria:
[1] All studies conducted in India on this topic regardless of their design, purpose or population.
[2] Incidence
[3] Prevalence
[4] Number of cases
[5] Mortality
[6] Burden
[7] Complications
[8] Virus serotype details / seroprevalence
2 reviewers independently collected data from selected papers using a predefined data extraction form. Any discrepancies in it were resolved through consensus. The information that was extracted from studies includes year of publication, study setting, location, period, laboratory investigations, number of suspected patients tested & found positive, the age distribution of cases and details of dengue serotypes as shown in Table 1, Table 2, Table 3, Table 4, Table 5 to Table 6 (dataset I -VI).
Table 1. Dataset I-DG Proportion.
| Sr. No. | Reference No. | Author | Year of Publication | Year of study | Country | Study Type (Hospital/Outbreak) | Case Definition Referred | Number of patients tested (Total) | Number of people tested positive (Event) |
| 1 | 12 | Abhilash et al. | 2016 | 2012-2013 | India | Hospital | AFI | 1258 | 386 |
| 2 | 13 | Afreen et al. | 2015 | 20112014 | India | Hospital | AFI | 604 | 416 |
| 3 | 14 | Ahir et al. | 2016 | 2014-2015 | India | Hospital | Clinical Suspected Dengue | 1146 | 148 |
| 4 | 15 | Ahmad et al. | 2016 | 2012-2013 | India | Hospital | AFI | 298 | 93 |
| 5 | 16 | Ahmed et al. | 2015 | 2010 | India | Hospital | Clinical Suspected Dengue | 4370 | 1700 |
| 6 | 17 | Amudhan et al. | 2015 | 2010-2013 | India | Hospital | Clinical Suspected Dengue | 4578 | 1185 |
| 7 | 18 | Anand et al. | 2016 | 2011 | India | Hospital | WHO | 112 | 94 |
| 8 | 19 | Arora et al. | 2021 | 2015 | India | Hospital | Clinical Suspected Dengue | 647 | 170 |
| 9 | 20 | Badoni et al. | 2023 | 2018-2019 | India | Hospital | Clinical Suspected Dengue | 279 | 222 |
| 10 | 21 | Barde et al. | 2014 | 2011-2012 | India | Hospital | NVBDCP | 138 | 21 |
| 11 | 22 | Barde et al. | 2015 | 2013 | India | Outbreak | NVBDCP | 648 | 321 |
| 12 | 23 | Barde et al. | 2015 | 2012 | India | Outbreak | WHO | 247 | 115 |
| 13 | 24 | Barua et al. | 2016 | 2014 | India | Hospital | AFI | 156 | 101 |
| 14 | 25 | Bhattacharya et al. | 2017 | 2013 | India | Hospital | Clinical Suspected Dengue | 218 | 168 |
| 15 | 26 | Biswas et al. | 2014 | 2012 | India | Outbreak | Clinical Suspected Dengue | 100 | 79 |
| 16 | 27 | Chakravarti et al. | 2014 | 2013 | India | Hospital | Clinical Suspected Dengue | 700 | 280 |
| 17 | 28 | Changal et al. | 2016 | 2015 | India | Hospital | Clinical Suspected Dengue | 225 | 114 |
| 18 | 29 | Deshkar et al. | 2017 | 2012-2016 | India | Hospital | Clinical Suspected Dengue | 15606 | 3822 |
| 19 | 30 | Dhingra et al. | 2020 | Feb 2014-Oct 2015 | India | Hospital | Clinical Suspected Dengue | 255 | 216 |
| 20 | 31 | Dinkar et al. | 2020 | 2012-2017 | India | Hospital | Clinical Suspected Dengue | 900 | 461 |
| 21 | 32 | Duthade et al. | 2015 | 2014 | India | Hospital | Clinical Suspected Dengue | 872 | 233 |
| 22 | 33 | Gopal et al. | 2016 | 2013 | India | Hospital | Clinical Suspected Dengue | 50 | 25 |
| 23 | 34 | Gopinath et al. | 2023 | 2018-2022 | India | Hospital | Clinical Suspected Dengue | 1383 | 286 |
| 24 | 35 | Gusani et al. | 2017 | 2014 | India | Hospital | NVBDCP | 765 | 331 |
| 25 | 36 | Henna et al. | 2014 | 2010-2012 | India | Hospital | Clinical Suspected Dengue | 7836 | 2807 |
| 26 | 36 | Henna et al. | 2014 | 2012-2013 | India | Hospital | Clinical Suspected Dengue | 2228 | 527 |
| 27 | 37 | Islam et al. | 2016 | 2015 | India | Hospital | AFI | 62 | 18 |
| 28 | 38 | Jindal et al. | 2014 | 2011 | India | Hospital | Clinical Suspected Dengue | 1787 | 586 |
| 29 | 39 | Joshua et al. | 2016 | 2014-2015 | India | Hospital | Clinical Suspected Dengue | 4952 | 2442 |
| 30 | 40 | Kartick et al. | 2017 | 2014 | India | Outbreak | Clinical Suspected Dengue | 62 | 27 |
| 31 | 41 | Kaup et al. | 2014 | 2013-2014 | India | Hospital | Clinical Suspected Dengue | 278 | 62 |
| 32 | 42 | Khan et al. | 2014 | 2012 | India | Hospital | Clinical Suspected Dengue | 164 | 107 |
| 33 | 43 | Lall et al. | 2016 | 2015 | India | Hospital | Clinical Suspected Dengue | 3163 | 646 |
| 34 | 44 | Laul et al. | 2016 | 2015 | India | Hospital | Clinical Suspected Dengue | 192 | 115 |
| 35 | 45 | Madan et al. | 2018 | Jun-Aug 2016 | India | Hospital | Clinical Suspected Dengue | 471 | 102 |
| 36 | 46 | Mehta et al. | 2014 | 2008-2011 | India | Hospital | WHO | 903 | 253 |
| 37 | 47 | Mishra et al. | 2015 | 2009-2012 | India | Hospital | Clinical Suspected Dengue | 433 | 136 |
| 38 | 48 | Mistry et al. | 2015 | 2013 | India | Hospital | Clinical Suspected Dengue | 4366 | 1802 |
| 39 | 49 | Mital et al. | 2016 | 2015 | India | Hospital | AFI | 90 | 61 |
| 40 | 50 | Muruganandham et al. | 2014 | 2013 | India | Outbreak | WHO | 23 | 13 |
| 41 | 51 | Neeraja et al. | 2014 | 2011-2013 | India | Hospital | Clinical Suspected Dengue | 175 | 109 |
| 42 | 52 | Nikam et al. | 2015 | 2014 | India | Hospital | Clinical Suspected Dengue | 1090 | 300 |
| 43 | 53 | Nisarta et al. | 2016 | 2015-2016 | India | Hospital | Clinical Suspected Dengue | 90 | 21 |
| 44 | 54 | Nujum et al. | 2014 | 2011 | India | Hospital | WHO | 851 | 174 |
| 45 | 55 | Padhi et al. | 2014 | 2010-2012 | India | Hospital | WHO | 5102 | 1074 |
| 46 | 56 | Padmapriya et al. | 2017 | 2009-2014 | India | Hospital | Clinical Suspected Dengue | 10099 | 1927 |
| 47 | 57 | Palewar et al. | 2023 | 2014-2020 | India | Hospital | Clinical Suspected Dengue | 6495 | 4689 |
| 48 | 58 | Patankar et al. | 2014 | 2012 | India | Hospital | Clinical Suspected Dengue | 4401 | 927 |
| 49 | 59 | Patil et al. | 2020 | Jan 2019-Dec 2019 | India | Hospital | WHO | 640 | 220 |
| 50 | 60 | Pothapregada et al. | 2016 | 2012-2015 | India | Hospital | WHO | 398 | 261 |
| 51 | 61 | Prakash et al. | 2015 | 2011-2013 | India | Hospital | Clinical Suspected Dengue | 4019 | 886 |
| 52 | 62 | Prakash et al. | 2023 | 2021 | India | Hospital | Clinical Suspected Dengue | 250 | 85 |
| 53 | 63 | Prudhivi et al. | 2014 | 2013 | India | Hospital | Clinical Suspected Dengue | 1180 | 284 |
| 54 | 64 | Ramachandran et al. | 2016 | 2010 | India | Hospital | Clinical Suspected Dengue | 1666 | 930 |
| 55 | 65 | Rao et al. | 2016 | 2013 | India | Hospital | Clinical Suspected Dengue | 1980 | 745 |
| 56 | 66 | Saravanan et al. | 2017 | 2012 | India | Outbreak | NVBDCP | 600 | 260 |
| 57 | 67 | Saswat et al. | 2015 | 2013 | India | Hospital | Clinical Suspected Dengue | 204 | 73 |
| 58 | 68 | Savargaonkar et al. | 2018 | 2012-2015 | India | Hospital | Clinical Suspected Dengue | 5536 | 1536 |
| 59 | 69 | Shabnum et al. | 2017 | 2015 | India | Hospital | Clinical Suspected Dengue | 1054 | 456 |
| 60 | 70 | Shah et al. | 2019 | 2014-2016 | India | Hospital | Clinical Suspected Dengue | 819 | 125 |
| 61 | 71 | Shaikh et al. | 2015 | 2010 | India | Hospital | Clinical Suspected Dengue | 6554 | 3202 |
| 62 | 72 | Sharma et al. | 2016 | 2015 | India | Hospital | WHO | 60 | 16 |
| 63 | 73 | Sharma et al. | 2014 | 2013 | India | Hospital | Clinical Suspected Dengue | 659 | 141 |
| 64 | 74 | Shobha et al. | 2014 | 2013 | India | Outbreak | WHO | 68 | 13 |
| 65 | 75 | Siddiqui et al. | 2016 | 2015 | India | Hospital | Clinical Suspected Dengue | 7177 | 2358 |
| 66 | 76 | Singh et al. | 2014 | 2013 | India | Hospital | AFI | 1141 | 812 |
| 67 | 77 | Singh et al. | 2016 | 2015-2016 | India | Hospital | Clinical Suspected Dengue | 2709 | 1538 |
| 68 | 78 | Singh et al. | 2016 | 2015 | India | Hospital | WHO | 1100 | 400 |
| 69 | 79 | Singh et al. | 2023 | 2022 | India | Outbreak | WHO | 63280 | 2060 |
| 70 | 80 | Singla et al. | 2015 | 2011-2012 | India | Hospital | AFI | 300 | 22 |
| 71 | 81 | Somasundaram et al. | 2019 | Jun 2017-Nov 2017 | India | Hospital | Clinical Suspected Dengue | 325 | 232 |
| 72 | 82 | Sushi et al. | 2014 | 2011 | India | Hospital | AFI | 100 | 8 |
| 73 | 83 | Tazeen et al. | 2017 | 2014 | India | Hospital | Clinical Suspected Dengue | 60 | 48 |
| 74 | 84 | Vakrani et al. | 2017 | 2013-2015 | India | Hospital | WHO | 139 | 101 |
| 75 | 85 | Venkatasubramani et al. | 2015 | 2010-2012 | India | Hospital | Clinical Suspected Dengue | 331 | 49 |
| 76 | 87 | Yogeesha et al. | 2014 | 2012 | India | Hospital | Clinical Suspected Dengue | 200 | 80 |
Table 2. Data set II-DG Age Distribution.
| Sr. No. | Reference No. | Author | Year of Publication | Year of study | Study. Type | Avg./Median Age |
| 1 | 16 | Ahmed et al. | 2015 | 2010 | Hospital | 25 |
| 2 | 89 | Athira et al. | 2018 | 2015-2017 | Hospital | 7.6 |
| 3 | 22 | Barde et al. | 2015 | 2012 | Outbreak | 33 |
| 4 | 23 | Barde et al. | 2015 | 2013 | Outbreak | 35 |
| 5 | 29 | Deshkar et al. | 2017 | 2012-2016 | Hospital | 14 |
| 6 | 32 | Duthade et al. | 2015 | 2014 | Hospital | 19 |
| 7 | 35 | Gusani et al. | 2017 | 2014 | Hospital | 24 |
| 8 | 89 | Jain et al. | 2017 | Aug-Nov 2015 | Hospital | 30.9 |
| 9 | 90 | John et al. | 2019 | 2014-2018 | Hospital | 31.3 |
| 10 | 41 | Kaup et al. | 2014 | 2013-2014 | Hospital | 26 |
| 11 | 91 | Kumar et al. | 2018 | Jan 2013-June 2014 | Hospital | 7.8 |
| 12 | 48 | Mishra et al. | 2015 | 2009-2012 | Hospital | 7 |
| 13 | 92 | Mishra et al. | 2018 | 2017 | Hospital | 33 |
| 14 | 49 | Mistry et al. | 2015 | 2013 | Hospital | 22 |
| 15 | 56 | Padhi et al. | 2014 | 2010-2012 | Hospital | 23 |
| 16 | 58 | Palewar et al. | 2023 | 2014-2020 | Hospital | 25 |
| 17 | 59 | Patankar et al. | 2014 | 2012 | Hospital | 23 |
| 18 | 60 | Patil et al. | 2020 | Jan 2019-Dec 2019 | Hospital | 35.3 |
| 19 | 93 | Pereira et al. | 2018 | Not Mentioned | Hospital | 32.41 |
| 20 | 64 | Prudhivi et al. | 2014 | 2013 | Hospital | 32 |
| 21 | 66 | Rao et al. | 2016 | 2013 | Hospital | 17 |
| 22 | 94 | Ravikumar et al. | 2021 | Aug-Dec 2020 | Hospital | 8 |
| 23 | 67 | Saravanan et al. | 2016 | 2012 | Outbreak | 33 |
| 24 | 70 | Shabnum et al. | 2017 | 2015 | Hospital | 26 |
| 25 | 95 | Sharma et al. | 2014 | 2013 | Hospital | 16 |
| 26 | 83 | Sushi et al. | 2014 | 2011 | Hospital | 21 |
| 27 | 96 | Swain et al. | 2019 | 2010-2016 | Hospital | 31.6 |
| 28 | 88 | Yogeesha et al. | 2014 | 2012 | Hospital | 35 |
| 29 | 97 | Esther et al. | 2023 | 2012-2017 | Hospital | 32 |
Table 3. Dataset III-DG Fever (FV) and DG Severity (SV).
| Sr. No. | Reference No. | Author | Year of Publication | Year of study | WHO Case Definition Reference | Dengue Positives | DF | Severe |
| 1 | 12 | Abhilash et al. | 2016 | 2012-2013 | WHO 1997 | 386 | 329 | 57 |
| 2 | 16 | Ahmed et al. | 2015 | 2010 | WHO 1997 | 1700 | 1525 | 175 |
| 3 | 19 | Arora et al. | 2021 | 2015 | WHO 2009 | 170 | 106 | 34 |
| 4 | 89 | Athira et al. | 2018 | 2015-2017 | WHO 2009 | 34 | 31 | 11 |
| 5 | 28 | Changal et al. | 2016 | 2015 | WHO 1997 | 114 | 84 | 30 |
| 6 | 98 | Chatterjee et al. | 2014 | 2012 | WHO 1997 | 180 | 128 | 52 |
| 7 | 99 | Chhotala et al. | 2016 | 2014-2015 | WHO 1997 | 100 | 94 | 6 |
| 8 | 100 | Deme et al. | 2021 | August 2018-October 2019 | WHO 2012 | 200 | 200 | 116 |
| 9 | 29 | Deshkar et al. | 2017 | 2012-2016 | WHO 1997 | 3822 | 3341 | 481 |
| 10 | 101 | Deshmukh et al. | 2014 | 2012-2014 | WHO 1997 | 247 | 173 | 74 |
| 11 | 30 | Dhingra et al. | 2020 | Feb 2014-Oct 2015 | WHO 2013 | 216 | 94 | 33 |
| 12 | 90 | John et al. | 2019 | April 2014-October 2018 | WHO 2012 | 369 | 198 | 171 |
| 13 | 102 | Kumar et al. | 2017 | 2015-2016 | WHO 1997 | 159 | 69 | |
| 14 | 91 | Kumar et al. | 2018 | Jan 2013-June 2014 | WHO 2012 | 40 | 20 | 20 |
| 15 | 44 | Laul et al. | 2016 | 2015 | WHO 1997 | 306 | 119 | 56 |
| 16 | 103 | Meena et al. | 2016 | 2014 | WHO 1997 | 115 | 89 | 26 |
| 17 | 104 | Mishra et al. | 2016 | 2013-2015 | WHO 2007 | 100 | 84 | 16 |
| 18 | 105 | Misra et al. | 2015 | 2003-2014 | WHO 1997 | 97 | 84 | 13 |
| 19 | 55 | Padhi et al. | 2014 | 2010-2012 | WHO 1997 | 116 | 82 | 34 |
| 20 | 93 | Pereira et al. | 2018 | Not Mentioned | WHO 2009 | 1074 | 1048 | 26 |
| 21 | 106 | Pothapregada et al. | 2015 | 2012-2014 | WHO 2007 | 550 | 547 | 101 |
| 22 | 107 | Rathod et al. | 2018 | 2013-2015 | WHO 2009 | 254 | 159 | 95 |
| 23 | 94 | Ravikumar et al. | 2021 | Aug-Dec 2020 | WHO 2009 | 100 | 100 | 11 |
| 24 | 108 | Sahana et al. | 2015 | 2012-2013 | WHO 2007 | 44 | 43 | 30 |
| 25 | 73 | Sharma et al. | 2016 | 2015 | WHO 1997 | 81 | 61 | 20 |
| 26 | 109 | Sil et al. | 2016 | 2015-2016 | WHO 1997 | 16 | 5 | 11 |
| 27 | 78 | Singh et al. | 2016 | 2015 | WHO 1997 | 71 | 62 | 9 |
| 28 | 110 | Singh et al. | 2022 | Sept-Dec 2019 | WHO 1997 | 400 | 260 | 140 |
| 29 | 81 | Somasundaram et al. | 2019 | Jun 2017-Nov 2017 | WHO 2012 | 1349 | 459 | 34 |
| 30 | 111 | Srividhya et al. | 2017 | 2013 | WHO 1997 | 232 | 232 | 38 |
| 31 | 84 | Vakrani et al. | 2017 | 2013-2015 | WHO 1997 | 140 | 70 | 70 |
Table 4. Dataset IV.
| Sr. No. | Reference No. | Author | Year of Publication | Year study | Total Positive for Dengue | No. of Mortality |
| 1 | 12 | Abhilash et al. | 2016 | 2012-2013 | 386 | 9 |
| 2 | 112 | Acharya et al. | 2018 | 2017-2018 | 364 | 14 |
| 3 | 15 | Ahmad et al. | 2016 | 2012-2013 | 93 | 4 |
| 4 | 16 | Ahmed et al. | 2015 | 2010 | 1700 | 1 |
| 5 | 21 | Barde et al. | 2014 | 2011-2012 | 21 | 0 |
| 6 | 22 | Barde et al. | 2015 | 2012 | 321 | 5 |
| 7 | 24 | Barua et al. | 2016 | 2014 | 101 | 1 |
| 8 | 113 | Bhalla et al. | 2014 | 2011 | 299 | 2 |
| 9 | 25 | Bhattacharya et al. | 2017 | 2013 | 168 | 0 |
| 10 | 98 | Chatterjee et al. | 2014 | 2012 | 180 | 7 |
| 11 | 99 | Chhotala et al. | 2016 | 2014-2015 | 100 | 4 |
| 12 | 29 | Deshkar et al. | 2017 | 2012-2016 | 3822 | 40 |
| 13 | 101 | Deshmukh et al. | 2014 | 2012-2014 | 247 | 11 |
| 14 | 114 | Deshwal et al. | 2015 | 2013 | 515 | 4 |
| 15 | 30 | Dhingra et al. | 2020 | Feb 2014-Oct 2015 | 216 | 13 |
| 16 | 32 | Duthade et al. | 2015 | 2014 | 233 | 5 |
| 17 | 90 | Jain et al. | 2017 | 2015 | 369 | 19 |
| 18 | 115 | Krishnamoorthy et al. | 2017 | 2013 | 1308 | 23 |
| 19 | 105 | Mishra et al. | 2016 | 2013-2015 | 97 | 1 |
| 20 | 116 | Nagaram et al. | 2017 | 2015-2016 | 174 | 9 |
| 21 | 51 | Neeraja et al. | 2014 | 2011-2013 | 109 | 9 |
| 22 | 117 | Nimmagadda et al. | 2014 | 2010-2012 | 150 | 3 |
| 23 | 118 | Padyana et al. | 2019 | 2015 | 1170 | 20 |
| 24 | 119 | Pai Jakribettu et al. | 2015 | 2013-2014 | 60 | 2 |
| 25 | 106 | Pothapregada et al. | 2015 | 2012-2014 | 254 | 6 |
| 26 | 106 | Pothapregada et al. | 2015 | 2012-2014 | 261 | 6 |
| 27 | 62 | Prakash P | 2023 | 2021 | 85 | 2 |
| 28 | 65 | Rao et al. | 2016 | 2013 | 745 | 0 |
| 29 | 108 | Sahana et al. | 2015 | 2012-2013 | 81 | 2 |
| 30 | 120 | Sahu et al. | 2014 | 2011-2013 | 486 | 5 |
| 31 | 66 | Saravanan et al. | 2016 | 2012 | 260 | 7 |
| 32 | 121 | Saroch et al. | 2017 | 2015 | 172 | 16 |
| 33 | 72 | Sharma et al. | 2016 | 2015-2016 | 200 | 0 |
| 34 | 73 | Sharma et al. | 2016 | 2015-2016 | 107 | 0 |
| 35 | 95 | Sharma et al. | 2014 | 2013 | 141 | 0 |
| 36 | 76 | Singh et al. | 2014 | 2013 | 812 | 12 |
| 37 | 79 | Singh et al. | 2023 | Sept-Dec 2019 | 1349 | 6 |
| 38 | 122 | Singhal et al. | 2020 | 2017 | 575 | 15 |
| 39 | 111 | Srividya et al. | 2017 | 2013 | 140 | 1 |
| 40 | 84 | Vakrani et al. | 2017 | 2013-2015 | 101 | 0 |
Table 5. Dataset V.
| Sr. No. | Reference No. | Author | Year of Publication | Year of study | Total Tested | Primary (PM) | Secondary (SC) |
| 1 | 22 | Barde et al. | 2015 | 2012 | 115 | 111 | 4 |
| 2 | 28 | Changal et al. | 2016 | 2015 | 114 | 38 | 76 |
| 3 | 33 | Gopal et al. | 2016 | 2013 | 25 | 13 | 12 |
| 4 | 41 | Kaup et al. | 2014 | 2013-2014 | 62 | 52 | 10 |
| 5 | 42 | Khan et al. | 2014 | 2012 | 87 | 82 | 5 |
| 6 | 104 | Mishra et al. | 2016 | 2013-2015 | 94 | 83 | 11 |
| 8 | 51 | Neeraja et al. | 2014 | 2011-2013 | 109 | 87 | 22 |
| 9 | 52 | Nikam et al. | 2015 | 2014 | 300 | 224 | 76 |
| 10 | 56 | Padmapriya et al. | 2017 | 2009-2014 | 1752 | 1124 | 628 |
| 11 | 65 | Rao et al. | 2016 | 2013 | 22 | 21 | 1 |
| 12 | 123 | Rashmi et al. | 2015 | 2014 | 97 | 93 | 4 |
| 13 | 114 | Shabnum et al. | 2017 | 2015 | 456 | 442 | 14 |
| 14 | 75 | Siddiqui et al. | 2016 | 2015 | 76 | 24 | 52 |
| 15 | 84 | Vikram et al. | 2016 | 2013 | 22 | 8 | 14 |
Table 6. Dataset VI.
| Sr. No. | Reference No. | Author | Year of Publication | Year study | Total Tested | Tested as Seropositive |
| 1 | 125 | Alagarasu et al. | 2023 | 2009-2019 | 2451 | 1963 |
| 2 | 20 | Badoni et al. | 2023 | 2018-2019 | 279 | 143 |
| 3 | 126 | Garg et al. | 2017 | 2011-2012 | 2558 | 1525 |
| 4 | 127 | Lakshmi et al. | 2022 | 2016-2019 | 5147 | 1314 |
| 5 | 124 | Mishra et al. | 2018 | 2017 | 1434 | 1163 |
| 6 | 128 | Murhekar et al. | 2019 | 2017-2018 | 12300 | 5338 |
| 7 | 129 | Oruganti et al. | 2014 | Not mentioned | 200 | 179 |
| 8 | 59 | Patil et al. | 2020 | Jan 2019-Dec 2020 | 640 | 398 |
| 9 | 130 | Rodríguez-Barraquer et al. | 2015 | 2011 | 800 | 744 |
| 10 | 131 | Vikram et al. | 2016 | 2013 | 1899 | 542 |
Data extraction & Review synthesis:
3 reviewers carried out the initial screening. The collected literature was first searched to remove duplicates before being entered into Rayyan software [132]. After that, the titles and abstracts were screened. In 2nd screening phase, 3 reviewers evaluated the selected papers based on their compliance with the eligibility standards. While the 2, independently shortlisted studies that met the design, participant and result requirements. Disagreements were resolved by discussion and, if necessary, the involvement of a 3rd reviewer. Using a pre-designed data extraction form in Microsoft Excel, 3 reviewers independently gathered details from the selected research. Initially, the search results were imported into Mendeley software (Version 1.19.6) where duplicate records were removed.
The outcome measures were:
[1] The prevalence of laboratory-confirmed dengue infection among clinically suspected patients in the research area, as reported in hospital/laboratory or community-based investigations during outbreaks.
[2] Seroprevalence of dengue in the study population dengue fever conditions, dengue severity and Mortality rate among dengue patients those were confirmed in labs.
[3] Primary and secondary infections present.
[4] Cost of illness/burden which included reported direct and indirect costs associated with dengue hospitalization.
[5] The non-structural protein-1 (NS1) antigen, immunoglobulin M (IgM) antibodies against dengue virus, haem-agglutination inhibition (HI) antibodies against dengue virus, RT-PCR positivity, or virus isolation was used to diagnose acute dengue infection in the clinically suspected patients. The measurement of IgG or neutralizing antibodies against the dengue virus was used to determine the seroprevalence of dengue.
Quality/Risk of bias assessment:
We utilized a modified version of the Joanna Briggs Institute (JBI) appraisal checklist for assessing prevalence data [133], along with key components from the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist [134] to gauge potential bias. Our primary criteria for bias assessment included outcome variables, laboratory testing procedures and participant selection strategies (refer to Supplementary file S2 Appendix). 2nd reviewers independently evaluated bias risk, resolving any disagreements through discussion. In cases of unresolved disputes, the perspective of a 3rd reviewer was sought and any disagreements were resolved. When needed, the viewpoint of the 3rd reviewer was sought.
Statistical analysis:
Using the single user licenced version of STATA 18.5 StataCorp LLC, Texas, USA, software and R-Studio analysis was carried out. The proportions from the combined data were shown along with their 95% confidence intervals (CI). Heterogeneity was assessed using an I2-test, where values below 25% indicated mild heterogeneity, values between 25 and 75% indicated moderate heterogeneity and values over 75% indicated significant heterogeneity [15, 16]. Based on the inverse variance approach for weighting, the Der-Simonian-Laird method for a random-effects model was used to compute the total pooled prevalence. Both the pooled estimates for the general and subgroup analyses and the study-specific estimates for each participant were shown using forest plots. To further demonstrate publication bias, a funnel plot was made.
Results:
Initially, we searched 6582 published articles in various electronic databases such as PubMed-2281, Ovid/Medline-47, Web of Science-4037 and Google Scholar-217 published. This was later on narrowed down to 999 unique articles after duplicate removal over the last 10 years. Following titles and abstracts screening, 613 articles were excluded, leaving 386 articles for full-text evaluation. This resulted in 127 studies being selected for analysis [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139-140] as shown in (Figure 1 see PDF).
Prevalence/proportion of laboratory dg cases & outbreak:
The clinically suspected patients are provided by 78 out of the 127 published studies included in this synthesis. This comprised 8 studies reporting outbreak investigations and 71 studies conducted in hospital or laboratory settings. A proportion of the studies that the hospital validated were conducted at the time; that the affected areas were going through an outbreak. The data of laboratory-confirmed cases by month were supplied by 32 research (40.5%) out of the 79 studies that reported a proportion of dengue cases; the majority of these studies (n = 53, 67%) indicated increased dengue positivity throughout the rainy seasons, particularly from July to October. The majority of the forty-seven investigations identified acute dengue infection using a single test, as follows: detection of the NS1 antigen = 1, virus isolation = 1, RT-PCR (Real-Time Reverse Transcription - Polymerase Chain) = 7, haem-agglutination inhibition antibodies = 2 and IgM antibodies = 36. The other studies employed multiple tests.
Case definitions used:
While discussed about case studies their; we took assistance of WHO (World Health Organizations), NVBDCP (National Center for Vector Borne Diseases Control) & AFI (Acute Febrile Illness) case definitions. Out of 79 studies during hospital settings majority n=53 were clinical suspected dengue followed by n=13 WHO case definition, n=9 AFI case definition and the remaining studies n=4 were used NVBDCP case definitions respectively. Both hospital confirmed dengue study and showed similarly, among 71 hospital confirmed dengue cases n=51 were clinical suspected dengue followed by n=9 WHO case definition, n=9 AFI case definition and the remaining studies n=2 were used NVBDCP case definitions respectively. Among the reported outbreaks, investigators used n=4 WHO case definition, n=2 AFI case definition and the remaining studies n=2 were used NVBDCP case definitions respectively.
Dengue proportion in India:
Based on testing of 206783 clinically suspected individuals from 78 studies, the overall estimate of the prevalence of laboratory-confirmed dengue infection in the random effects model was 39.4% (95% CI: 35.6%-44.67%) as shown in (Figure 2 see PDF). The heterogeneity was assessed by Hedge g statistics. The heterogeneity overcomes by using random effect model as shown in (Figure 3 see PDF). The publication biased(PB) was assessed by using funnel plot, some asymmetry observed because individual study had different proportion and this was directly impacts on shifting the points on funnel to outside but the both the side almost normality hence in our study there was no publication bias was reporting as shown in. The prevalence reported by the 79 studies showed significant heterogeneity (LRT p<0.001). In comparison to hospital-based surveillance (HBS) studies (40%, 95% CI: 35-44), the prevalence of laboratory-confirmed dengue infection was nearly identical in studies reporting outbreaks (OB) or hospital-based surveillance studies during outbreaks (39%, 95% CI: 34-44).
Age distribution:
Data was available for 30 out of 127 studies on laboratoryconfirmed DG cases. The overall average age of confirmed DG patients in this study was 24.47 years; with a standard deviation of 9.22 years with age range was 7 to 36 years as shown in (Figure 4 - see PDF).
Dg-FV & Dg-S proportion:
31 studies provided information on dengue fever, while 32 studies provided information on dengue symptoms. The majority of the research (n = 19, 59.38%) utilized the WHO 1997 classification, while the remaining studies (n = 3, 9.38%) employed the WHO 2007 classification. Additionally, for dengue fever condition and severity, (n = 6, 18.75%) used the WHO 2009 classification, whereas 4 studies (12.5%) used the WHO 2012 classification. It was reported that between 31% and 100% of laboratory-confirmed patients had dengue fever. According to the random effect model, 75% (95% CI: 67-82) of laboratory-confirmed studies exhibited dengue fever overall. The Hedges g-Method (HD-M) was used to estimate the random effect model, indicating no heterogeneity as shown in (Figure 5 see PDF). Bias in publications observed and depicted that higher prevalence publications were more side. On the other hand, among patients with laboratory-confirmed, the reported percentage of dengue symptoms cases varied from 2% to 69%. In the random effect model (REM), the total percentage of dengue symptoms across laboratory-confirmed studies was 25% (95% CI: 19-31). The data on dengue symptoms showed no evidence of heterogeneity as shown in (Figure 6 see PDF).
DG Mortality (MT) in India:
In the provided research, 48 provided information on MT rate of DG, It was reported that between 0% and 9% of LB-CN patients had DG-FV. According to the REM, 1% (95% CI: 1-2) of LB-CN studies exhibited DG-FV overall. The HD-M was used to estimate the REM, indicating no HTG. Bias in publications observed and depicted that higher prevalence publications was more side, The removal of the study with greatest weight in each LB-CN test of DG disease did not change the results.
Pm-if & SC among dg cases in India:
A comprehensive analysis of 15 studies [31, 37, 48, 59-60, 71, 78, 81- 82, 89, 104- 105, 115, 124] enabled the categorization of LB-CN-DG-IF into PM and SC. The prevalence of initial DG-IF varied widely ranges from 32% to 97% across the studies. Overall, PM-DG-IF accounted for 77% of LB-CN cases (95% CI: 65-87). Meanwhile, SC-DG-IF occurred in 23% of LB-CN cases (95% CI: 13-35), with a range of 3% to 68% across the studies.
PB-BA & sensitivity statistics (SS-ST):
There was no indication of publication bias in the dengue prevalence estimates from hospital-based studies with LB-CN cases, outbreaks & SP according to analysis utilizing funnel plots and the HD approach. The estimates of dengue severity and fatality did, however, reveal a substantial publication BA, with publications demonstrating higher prevalence being more likely to be published. However, sensitivity analysis showed that the pooled percentages of research results held steady, suggesting the estimates' resilience. The removal of the study with greatest weight in each dengue cases LB-CN did not change the results.
Discussion:
The analysis primarily drew on data from HB and laboratorybased surveillance studies, as well as reports from investigations into dengue outbreaks. There have been more than 10 million reported cases of dengue along with over 5,000 dengue-related deaths across 80 countries. The Pan American Health Organization (PAHO) region has reported the majority of cases, with over nine million cases. Within the PAHO region, Brazil has reported the highest number of cases (over eight million), followed by Argentina, Paraguay, Peru and Colombia. In Europe, imported cases from endemic areas have been reported in Germany, Italy and France, but no locally acquired cases have been reported.
Dengue circulation has also been reported in the Southeast Asia and Western Pacific regions, as well as in Africa. It concentrated on their operations, implementation and structure. The WHO had set aggressive goals to cut dengue-related mortality by 50% and morbidity by 25% along with burden by 2020 [135-136]. A recent study in Brazil found a significant disparity in the infection rates between wealthy and disadvantaged youth. Specifically, the study revealed that 60% of young people from disadvantaged backgrounds were infected, which is three times the rate of their wealthier peers and our study also found similar kind of results where average age was 24.4 years [137]. Overall, 127 studies with a total of 3Lacs population were covered for study of dengue disease in our country. Viral assays are used in laboratories to confirm dengue infection (RNA detection by RTPCR, NS1 antigen detection by ELISA) [138]. The overall prevalence of dengue disease in our India based on testing of 206783 clinically suspected individuals from 79 studies, the overall estimate of the prevalence of laboratory-confirmed - dengue infection in the random effect model was 39.4% (95% CI: 35.6%-44.67%) According to a study, the overall prevalence of dengue in country like India based on testing 206783 clinically suspected individuals from 79 different studies was 39.4% [139].
There are also research gaps in India's understanding of dengue epidemiology and the fact that different types of the dengue virus are still being spread. These factors show that dengue is still a major public health issue in India. The high percentage of dengue-positive cases, severity and case mortality in India are all indicators that dengue continues to be a significant public health concern in the country. As a consequence of this, it is required to undertake community-based cohort studies that are wellstructured and cover a variety of geographical locations of the country in order to offer reliable estimates of the age-specific incidence of dengue fever in India [140].
Conclusion:
DG-FV remains a pressing public health issue in India, as indicated by its high incidence, severity and mortality rates, as well as the circulation of multiple virus serotypes. To better comprehend the epidemic, we suggest conducting in-depth research, including community-based studies across various regions to determine age-specific incidence rates. Alternatively, a nationwide survey could be undertaken to determine age-specific seroprevalence rates, which also includes targeted studies in different geographic areas in India.
Limitation:
[1] We have restricted our search to quantitative sides which might be neglected towards qualitative enrichment of variables
[2] We considered peer-reviewed journals database from certain articles, which lead to exclusion of government registries data as a grey literature that could provide other aspects of the picture too.
Future research:
We should implement active surveillance systems, scaling up vector control measures, enhance more public awareness & education and finally, strengthen the prevention strategies.
Edited by Neelam Goyal & Shruti Dabi
Citation: Mane et al. Bioinformation 20(11):1221-1232(2024)
Declaration on Publication Ethics: The author's state that they adhere with COPE guidelines on publishing ethics as described elsewhere at https://publicationethics.org/. The authors also undertake that they are not associated with any other third party (governmental or non-governmental agencies) linking with any form of unethical issues connecting to this publication. The authors also declare that they are not withholding any information that is misleading to the publisher in regard to this article.
Declaration on official E-mail: The corresponding author declares that official e-mail from their institution is not available for all authors.
License statement: This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License
Comments from readers: Articles published in BIOINFORMATION are open for relevant post publication comments and criticisms, which will be published immediately linking to the original article without open access charges. Comments should be concise, coherent and critical in less than 1000 words.
Bioinformation Impact Factor:Impact Factor (Clarivate Inc 2023 release) for BIOINFORMATION is 1.9 with 2,198 citations from 2020 to 2022 taken for IF calculations.
Disclaimer:The views and opinions expressed are those of the author(s) and do not reflect the views or opinions of Bioinformation and (or) its publisher Biomedical Informatics. Biomedical Informatics remains neutral and allows authors to specify their address and affiliation details including territory where required. Bioinformation provides a platform for scholarly communication of data and information to create knowledge in the Biological/Biomedical domain.
References
- 1.Stanaway JD, et al. The Lancet infectious diseases. . 2016;16:712. doi: 10.1016/S1473-3099(16)30218-3. [DOI] [PubMed] [Google Scholar]
- 2.WHO Guidelines Approved by the Guidelines Review Committee. . Geneva: World Health Organization. . 2009 [Google Scholar]
- 3.Asish PR, et al. Int J Infect Dis. . 2023;134:292. doi: 10.1016/j.ijid.2023.07.010. [DOI] [PubMed] [Google Scholar]
- 4.Murray NEA, et al. Clinical epidemiology. . 2013;20:299. doi: 10.2147/CLEP.S34440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Thomas L, et al. Am J Trop Med Hyg. . 2008;78:990. [PubMed] [Google Scholar]
- 6.Ross TM. Clinics in laboratory medicine. . 2010;30:149. doi: 10.1016/j.cll.2009.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Khetarpal N, Khanna I. Journal of immunology research. . 2016;2016:6803098. doi: 10.1155/2016/6803098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.St.John AL, Rathore APS. Nature Reviews Immunology. . 2019;19:218. doi: 10.1038/s41577-019-0123-x. [DOI] [PubMed] [Google Scholar]
- 9.Guzman MG, et al. Arch Virol. . 2013;158:1445. doi: 10.1007/s00705-013-1645-3. [DOI] [PubMed] [Google Scholar]
- 10.Salje H, et al. Nature. . 2018;557:719. doi: 10.1038/s41586-018-0157-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Page MJ, et al. BMJ. . 2021;29:372. [Google Scholar]
- 12.Abhilash KP, et al. J Glob Infect Dis. . 2016;8:147. doi: 10.4103/0974-777X.192966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Afreen N, et al. Microbiol Immunol. . 2014;58:688. doi: 10.1111/1348-0421.12209. [DOI] [PubMed] [Google Scholar]
- 14.Ahir HR, Vaghda GH. Int J Curr Microbiol Appl Sci. . 2016;5:96. doi: 10.20546/ijcmas.2016.511.010. [DOI] [Google Scholar]
- 15.Ahmad S, et al. Eur J Clin Microbiol Infect Dis. . 2016;35:705. doi: 10.1007/s10096-016-2590-3. [DOI] [PubMed] [Google Scholar]
- 16.Ahmed NH, Broor S. Indian J Community Med. . 2015;40:135. doi: 10.4103/0970-0218.153884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Amudhan M, et al. Indian J Med Microbiol. . 2015;33:458. doi: 10.4103/0255-0857.158605. [DOI] [PubMed] [Google Scholar]
- 18.Anand AM, et al. J Clin Diagn Res. . 2016;10:DC01. doi: 10.7860/JCDR/2016/15758.7562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Arora SK, et al. J Vector Borne Dis. . 2021;58:329. doi: 10.4103/0972-9062.318312. [DOI] [PubMed] [Google Scholar]
- 20.Badoni G, et al. Heliyon. . 2023;9:e14019. doi: 10.1016/j.heliyon.2023.e14019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Barde PV, et al. WHO South East Asia J Public Health. . 2014;3:36. doi: 10.4103/2224-3151.206881. [DOI] [PubMed] [Google Scholar]
- 22.Barde PV, et al. Indian J Med Res. . 2015;141:584. doi: 10.4103/0971-5916.159517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Barde PV, et al. Epidemiol Infect. . 2015;143:412. doi: 10.1017/S0950268814000612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Barua A, Gill N. J Assoc Physicians India. . 2016;64:49. [PubMed] [Google Scholar]
- 25.Bhattacharya PK, et al. Indian Journal of Medical Specialities. . 2017;8:124. doi: 10.1016/j.injms.2017.03.001. [DOI] [Google Scholar]
- 26.Biswas DK, et al. WHO South East Asia J Public Health. . 2014;3:46. doi: 10.4103/2224-3151.206883. [DOI] [PubMed] [Google Scholar]
- 27.Chakravarti A, Roy P. Trop Doct. . 2014;44:246. doi: 10.1177/0049475514543942. [DOI] [PubMed] [Google Scholar]
- 28.Changal KH, et al. BMC Infect Dis. . 2016;16:715. doi: 10.1186/s12879-016-2053-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Deshkar ST, et al. Int J Res Med Sci. . 2017;5:2483. doi: 10.18203/2320-6012.ijrms20172433. [DOI] [Google Scholar]
- 30.Dhingra H, et al. Pediatric Infectious Disease. . 2020;2:1. doi: 10.5005/jp-journals-10081-1235. [DOI] [Google Scholar]
- 31.Dinkar A, Singh J. Ci Ji Yi Xue Za Zhi. . 2019;32:36. [Google Scholar]
- 32.Duthade MM, et al. Int. J. Curr. Microbiol. App. Sci. . 2015;4:416. [Google Scholar]
- 33.Gopal K, et al. Annals of International medical and Dental Research. . 2016 doi: 10.21276/AIMDR.2016.2.6.MB2. [DOI] [Google Scholar]
- 34.Gopinath R, et al. Journal of Global Infectious Diseases. . 2023;15:144. doi: 10.4103/jgid.jgid_101_23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gusani JK, et al. Int. J. Curr Microbiol App. Sci. . 2017;6:2100. doi: 10.20546/ijcmas.2017.605.234. [DOI] [Google Scholar]
- 36.Henna ASa, et al. Dengue Bulletin. . 2014;38:43. [Google Scholar]
- 37.Islam A, et al. Indian Journal of Health Sciences and Care. . 2016;3:24. doi: 10.5958/2394-2800.2016.00005.5. [DOI] [Google Scholar]
- 38.Jindal N, et al. Asian Pacific Journal of Tropical Disease. . 2014;4:363. doi: 10.1016/S2222-1808(14)60588-0. [DOI] [Google Scholar]
- 39.Joshua V, et al. Indian Journal of Medical Research. . 2016;144:938. doi: 10.4103/ijmr.IJMR_673_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kartick C, et al. Epidemiology & Infection. . 2017;145:1437. doi: 10.1017/S0950268816003423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kaup S, et al. Scholars Journal of Applied Medical Sciences. . 2014;2:922. doi: 10.36347/sjams.2014.v02i03.007. [DOI] [Google Scholar]
- 42.Khan SA, et al. The Scientific World Journal. . 2014;2014:584093. [Google Scholar]
- 43.Lall H, et al. Int J Curr Microbiol Appl Sci. . 2016;5:439. doi: 10.20546/ijcmas.2016.506.051. [DOI] [Google Scholar]
- 44.Laul A, et al. Journal of tropical medicine. . 2016;2016:5917934. doi: 10.1155/2016/5917934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Madan SP, et al. Int J Health Sci Res. . 2018;8:43. [Google Scholar]
- 46.Mehta KD, et al. WHO South-East Asia Journal of Public Health. . 2014;3:72. doi: 10.4103/2224-3151.206888. [DOI] [PubMed] [Google Scholar]
- 47.Mishra G, et al. Journal of Medical Virology. . 2015;87:68. doi: 10.1002/jmv.23981. [DOI] [PubMed] [Google Scholar]
- 48.Mistry M, et al. Journal of vector borne diseases. . 2015;52:299. [PubMed] [Google Scholar]
- 49.Mital R, et al. Internat J Contemp Medic Res. . 2016;3:718. [Google Scholar]
- 50.Muruganandam N, et al. Journal of Vector Borne Diseases. . 2014;51:58. [PubMed] [Google Scholar]
- 51.Neeraja M, et al. Archives of virology. . 2014;159:1567. doi: 10.1007/s00705-014-2010-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Nikam AP, et al. Int J Med Res Rev. . 2015;3:593. doi: 10.17511/ijmrr.2015.i6.112. [DOI] [Google Scholar]
- 53.Nisarta A, et al. Int J Curr Microbiol App Sci. . 2016;5:819. doi: 10.20546/ijcmas.2016.510.089. [DOI] [Google Scholar]
- 54.Nujum ZT, et al. Pathogens and global health. . 2014;108:103. doi: 10.1179/2047773214Y.0000000131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Padhi S, et al. Indian Journal of Medical Research. . 2014;140:660. [PMC free article] [PubMed] [Google Scholar]
- 56.Padmapriya P, et al. Archives of virology. . 2017;162:273. doi: 10.1007/s00705-016-3040-3. [DOI] [PubMed] [Google Scholar]
- 57.Palewar MS, et al. Journal of Vector Borne Diseases. . 2023;60:238. doi: 10.4103/0972-9062.353232. [DOI] [PubMed] [Google Scholar]
- 58. https://pesquisa.bvsalud.org/portal/resource/pt/sea-153217 .
- 59.Patil PS, et al. J. Pure Appl Microbiol. . 2020;14:1935. doi: 10.22207/JPAM.14.3.32. [DOI] [Google Scholar]
- 60.Pothapregada S, et al. Journal of global infectious diseases. . 2016;8:115. doi: 10.4103/0974-777X.188596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Prakash O, et al. Indian Journal of Medical Research. . 2015;142:S7. doi: 10.4103/0971-5916.176596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Prakash P, et al. Journal of Family Medicine and Primary Care. . 2023;12:1525. doi: 10.4103/jfmpc.jfmpc_1176_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. https://pesquisa.bvsalud.org/portal/resource/pt/sea-165492 .
- 64.Ramachandran VG, et al. Virus disease. . 2016;27:183. [Google Scholar]
- 65.Rao MR, et al. Journal of Infection and Public Health. . 2016;9:421. doi: 10.1016/j.jiph.2015.10.019. [DOI] [PubMed] [Google Scholar]
- 66.Saravanan MSP, et al. Stanley Medical Journal. . 2017;3:44. [Google Scholar]
- 67.Saswat T, et al. Infection, Genetics and Evolution. . 2015;35:134. doi: 10.1016/j.meegid.2015.08.006. [DOI] [PubMed] [Google Scholar]
- 68.Savargaonkar D, et al. International Journal of Infectious Diseases. . 2018;74:41. doi: 10.1016/j.ijid.2018.06.020. [DOI] [PubMed] [Google Scholar]
- 69.Shabnum M, et al. J. Pathol. Microbiol. . 2017;2:10. doi: 10.21276/sjpm.2017.2.1.3. [DOI] [Google Scholar]
- 70.Shah PS, et al. BMC Infectious Diseases. . 2019;19:296. doi: 10.1186/s12879-019-3937-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Shaikh N, et al. Indian Journal of Medical Microbiology. . 2015;33:459. doi: 10.4103/0255-0857.158607. [DOI] [PubMed] [Google Scholar]
- 72.Sharma S, et al. Infectious diseases in obstetrics and gynecology. . 2016;2016:5046091. doi: 10.1155/2016/5046091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Sharma NL, et al. Int. J. Contemp Pediatr. . 2016;4:110. doi: 10.18203/2349-3291.ijcp20164588. [DOI] [Google Scholar]
- 74.Shobha S, et al. Int. J. Med. Sci. Public Health. . 2014;3:845. doi: 10.5455/ijmsph.2014.280420141. [DOI] [Google Scholar]
- 75.Siddiqui O, et al. Journal of clinical and diagnostic research. . 2016;10:DC01. doi: 10.7860/JCDR/2016/19238.7927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Singh R, et al. Journal of clinical and diagnostic research: JCDR. . 2014;8:MC01. doi: 10.7860/JCDR/2014/8965.4435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Singh K, et al. Journal of Clinical and Diagnostic Research: JCDR. . 2016;10:DC15. doi: 10.7860/JCDR/2016/22514.9019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Singh N, et al. Annals of Applied Bio-Sciences. . 2016;3:A158. [Google Scholar]
- 79.Singh N, et al. Indian Journal of Public Health. . 2023;67:181. doi: 10.4103/ijph.ijph_1517_22. [DOI] [PubMed] [Google Scholar]
- 80.Singla N, et al. Asian Pacific journal of tropical medicine. . 2015;8:206. doi: 10.1016/S1995-7645(14)60316-3. [DOI] [PubMed] [Google Scholar]
- 81.Somasundaram D, et al. Indian Journal of Child Health. . 2019;6:209. doi: 10.32677/IJCH.2019.v06.i05.004. [DOI] [Google Scholar]
- 82.Sushi KM, et al. Indian J Basic Appl Med Res. . 2014;3:615. [Google Scholar]
- 83.Tazeen A, et al. Epidemiology & Infection. . 2017;145:67. doi: 10.1017/S0950268816001990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Vakrani GP, et al. Journal of Clinical and Diagnostic Research: JCDR. . 2017;11:OC10. doi: 10.7860/JCDR/2017/22800.9289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Venkatasubramani K, et al. Tropical doctor. . 2015;45:197. doi: 10.1177/0049475515585476. [DOI] [PubMed] [Google Scholar]
- 86.Mandal SK, et al. National Journal of Medical Research. . 2013;3:173. [Google Scholar]
- 87.Yogeesha K, et al. International Journal of Recent Trends in Science and Technology. . 2014;10:373. [Google Scholar]
- 88.Athira PP, et al. Journal of Clinical & Diagnostic Research. . 2018;12:SC01. doi: 10.7860/JCDR/2018/34710.11756. [DOI] [Google Scholar]
- 89.Jain S, et al. In Open forum infectious diseases. . 2017;4:ofx056. doi: 10.1093/ofid/ofx056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.John KJ, et al. Interdisciplinary Perspectives on Infectious Diseases. . 2019;2019:4823791. doi: 10.1155/2019/4823791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Kumar BV, et al. Indian Journal of Child Health. . 2018;5:32. doi: 10.32677/IJCH.2018.v05.i01.008. [DOI] [Google Scholar]
- 92.Mishra AC, et al. PLoS neglected tropical diseases. . 2018;12:e0006657. doi: 10.1371/journal.pntd.0006657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Pereira MS, et al. Asian J Pharm Clin Res. . 2018;11:272. doi: 10.22159/AJPCR.2018.V11I3.23496. [DOI] [Google Scholar]
- 94.Ravikumar N, et al. The American Journal of Tropical Medicine and Hygiene. . 2021;105:751. [Google Scholar]
- 95.Sharma Y, et al. Journal of Clinical and Diagnostic Research: JCDR. . 2014;8:DC09. doi: 10.7860/JCDR/2014/.5270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Swain S, et al. Infectious diseases of poverty. . 2019;8:31. doi: 10.1186/s40249-019-0541-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Esther Annan, et al. PLoS Negl Trop Dis. . 2023;17:e0011537. doi: 10.1371/journal.pntd.0011537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Chatterjee N, et al. J Assoc Physicians India. . 2014;62:224. [PubMed] [Google Scholar]
- 99.Chhotala YH, et al. Int J Res Med Sci. . 2016;4:4500. doi: 10.18203/2320-6012.ijrms20163318. [DOI] [Google Scholar]
- 100.Deme S, et al. Int J of Mosquito Research . 2021;8:63. doi: 10.22271/23487941.2021.v8.i2a.520. [DOI] [Google Scholar]
- 101.Deshmukh JM, et al. Journal of Evolution of Medical and Dental Sciencesm, . 2014;3:9179. doi: 10.14260/jemds/2014/3184. [DOI] [Google Scholar]
- 102.Kumar BV, et al. Indian Journal of Child Health. . 2018;5:32. doi: 10.32677/IJCH.2018.v05.i01.008. [DOI] [Google Scholar]
- 103.Meena KC, et al. Int J Adv Med. . 2016;3:621. doi: 10.18203/2349-3933.ijam20162506. [DOI] [Google Scholar]
- 104.Mishra S, et al. Scientifica(Cairo). . 2016;2016:6391594. [Google Scholar]
- 105.Misra UK, et al. Journal of Clinical Virology. . 2015;72:146. doi: 10.1016/j.jcv.2015.08.021. [DOI] [PubMed] [Google Scholar]
- 106.Pothapregada S, et al. Indian journal of critical care medicine. . 2015;19:661. doi: 10.4103/0972-5229.169340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Rathod NP, et al. Pediatric Oncall Journal. . 2018;15:1. doi: 10.7199/ped.oncall.2018.13. [DOI] [Google Scholar]
- 108.Sahana KS, Sujatha R. The Indian Journal of Pediatrics. . 2015;82:109. doi: 10.1007/s12098-014-1523-3. [DOI] [PubMed] [Google Scholar]
- 109.Sil A, Amit Das. Global journal for research analysis. . 2016;5:95. [Google Scholar]
- 110.Singh V, et al. Medical journal armed forces India. . 2022;78:140. doi: 10.1016/j.mjafi.2020.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Srividya V, et al. Int J Community Med Public Health. . 2017;4:928. doi: 10.18203/2394-6040.ijcmph20170928. [DOI] [Google Scholar]
- 112.Acharya V, et al. Int J Res Med Sci. . 2018;6:1605. doi: 10.18203/2320-6012.ijrms20181495. [DOI] [Google Scholar]
- 113.Bhalla A, et al. International Journal of Infectious Diseases. . 2014;21:324. doi: 10.1016/j.ijid.2014.03.1089. [DOI] [Google Scholar]
- 114.Deshwal R, et al. J Assoc Physicians India. . 2015;63:30. [PubMed] [Google Scholar]
- 115.Krishnamoorthy S, et al. Tropical Doctor. . 2017;47:136. doi: 10.1177/0049475517691878. [DOI] [PubMed] [Google Scholar]
- 116.Nagaram PP, et al. Int J Contemp Pediatr. . 2017;4:1074. doi: 10.18203/2349-3291.ijcp20171731. [DOI] [Google Scholar]
- 117.Nimmagadda SS, et al. J Clin Diagn Res. . 2014;8:71. doi: 10.7860/JCDR/2014/6885.3960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Padyana M, et al. Indian Journal of Critical Care Medicine. . 2019;23:270. [Google Scholar]
- 119.Pai Jakribettu R, et al. Journal of tropical medicine. . 2015;2015:647162. doi: 10.1155/2015/647162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Sahu R, et al. Neurology. . 2014;83:1601. doi: 10.1212/WNL.0000000000000935. [DOI] [PubMed] [Google Scholar]
- 121.Saroch A, et al. Tropical Doctor. . 2017;47:141. doi: 10.1177/0049475517693993. [DOI] [PubMed] [Google Scholar]
- 122.Singhal T, Vatsal K. The American Journal of Tropical Medicine and Hygiene. . 2020;103:1223. [Google Scholar]
- 123.Rashmi MV, Hamsaveena The Malaysian Journal of Pathology. . 2015;37:247. [PubMed] [Google Scholar]
- 124.Mishra AC, et al. PLoS neglected tropical diseases. . 2018;12:e0006657. doi: 10.1371/journal.pntd.0006657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Alagarasu K, et al. Journal of Infection and Public Health. . 2023;16:1830. doi: 10.1016/j.jiph.2023.08.020. [DOI] [PubMed] [Google Scholar]
- 126.Garg S, et al. International Journal of Infectious Diseases. . 2017;54:25. [Google Scholar]
- 127.Lakshmi SD, et al. Int J Curr Microbiol Appl Sci. . 2018;7:43. doi: 10.20546/ijcmas.2018.709.006. [DOI] [Google Scholar]
- 128.Murhekar MV, et al. The Lancet Global health. . 2019;7:e1065. [Google Scholar]
- 129.Oruganti G, et al. Indian Journal of Public Health Research & Development. . 2014;5:131. doi: 10.5958/j.0976-5506.5.1.031. [DOI] [Google Scholar]
- 130.Rodríguez-Barraquer I, et al. PLoS neglected tropical diseases. . 2015;9:e0003906. doi: 10.1371/journal.pntd.0003906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Vikram K, et al. Acta tropica. . 2016;153:21. doi: 10.1016/j.actatropica.2015.09.025. [DOI] [PubMed] [Google Scholar]
- 132.Vandenbroucke JP, et al. Annals of internal medicine. . 2007;147:W163. doi: 10.7326/0003-4819-147-8-200710160-00010-w1. [DOI] [PubMed] [Google Scholar]
- 133.Zhao JG. Journal of Hand Surgery. . 2013;38:1449. doi: 10.1016/j.jhsa.2013.05.020. [DOI] [PubMed] [Google Scholar]
- 134.Deeks JJ, et al. Cochrane handbook for systematic reviews of interventions. . 2019;23:241. doi: 10.1002/9781119536604.ch10. [DOI] [Google Scholar]
- 135.Kumar MS, et al. The American Journal of Tropical Medicine and Hygiene. . 2021;105:1277. [Google Scholar]
- 136.Padmapriya P, et al. Archives of virology. . 2017;162:273. doi: 10.1007/s00705-016-3040-3. [DOI] [PubMed] [Google Scholar]
- 137.Indu PS, et al. The Lancet Regional Health-Southeast Asia. . 2024;22:100337. doi: 10.1016/j.lansea.2024.100385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Prakash P, et al. Journal of Family Medicine and Primary Care. . 2023;12:1525. doi: 10.4103/jfmpc.jfmpc_1176_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Padbidri VS, et al. Southeast Asian journal of tropical medicine and public health. . 2002;33:794. [PubMed] [Google Scholar]
- 140.Ganeshkumar P, et al. PLoS neglected tropical diseases. . 2018;12:e0006618. doi: 10.1371/journal.pntd.0006618. [DOI] [PMC free article] [PubMed] [Google Scholar]
